| [1] |
Blot S, Antonelli M, Arvaniti K, et al. Epidemiology of intra-abdominal infection and sepsis in critically ill patients: "AbSeS" a multinational observational cohort study and ESICM Trials Group Project[J]. Intensive Care Med, 2019, 45(12):1703-1717.
|
| [2] |
Fan JJ, Ding L, Lu YY, et al. Epidemiology and etiology of acute pancreatitis in urban and suburban areas in Shanghai: a retrospective study[J]. Gastroenterol Res Pract, 2018:1420590.
|
| [3] |
Guo YY, Li HX, Zhang Y, et al. Hypertriglyceridemia-induced acute pancreatitis: progress on disease mechanisms and treatment modalities[J]. Discov Med, 2019, 27(147):101-109.
|
| [4] |
Lee PJ, Papachristou GI. New insights into acute pancreatitis[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(8):479-496.
|
| [5] |
Constantinescu C, Pasca S, Tat T, et al. Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?[J]. J Immunother Cancer, 2020, 8(1):e000742.
|
| [6] |
Qiu L, Sun RQ, Jia RR, et al. Comparison of existing clinical scoring systems in predicting severity and prognoses of hyperlipidemic acute pancreatitis in Chinese patients: a retrospective study[J]. Medicine, 2015, 94(23):e957.
|
| [7] |
He WH, Yu M, Zhu Y, et al. Emergent triglyceride-lowering therapy with early high-volume hemofiltration against low-molecular-weight heparin combined with insulin in hypertriglyceridemic pancreatitis: a prospective randomized controlled trial[J]. J Clin Gastroenterol, 2016, 50(9):772-778.
|
| [8] |
Zádori N, Gede N, Antal J, et al. Early elimination of fatty acids in hypertriglyceridemia-induced acute pancreatitis (ELEFANT trial): protocol of an open-label, multicenter, adaptive randomized clinical trial[J]. Pancreatology, 2020, 20(3):369-376.
|
| [9] |
Chang EY, Odebunmi I, Umar A. Standardization of continuous renal replacement therapy[J]. JAMA Intern Med, 2018, 178(7):1002-1003.
|
| [10] |
Gao N, Yan CJ, Zhang GC. Changes of serum procalcitonin (PCT), C-reactive protein (CRP), interleukin-17 (IL-17), interleukin-6 (IL-6), high mobility group protein-B1 (HMGB1) and D-dimer in patients with severe acute pancreatitis treated with continuous renal replacement therapy (CRRT) and its clinical significance[J]. Med Sci Monit, 2018(24):5881-5886.
|
| [11] |
Lee KH, Sol IS, Park JT, et al. Continuous renal replacement therapy (CRRT) in children and the specialized CRRT team: a 14-year single-center study[J]. J Clin Med, 2019, 9(1):110.
|
| [12] |
Juncos LA, Chandrashekar K, Karakala N, et al. Vascular access, membranes and circuit for CRRT[J]. Semin Dial, 2021, 34(6):406-415.
|
| [13] |
Lin YJ, He SR, Gong JH, et al. Continuous veno-venous hemofiltration for severe acute pancreatitis[J]. Cochrane Database Syst Rev, 2019, 10(10):CD012959.
|
| [14] |
周佳. HP联合CVVH是治疗高脂血症性重症急性胰腺炎的效果评价[J]. 当代医学, 2019, 25(3):154-155.
|
| [15] |
Ankawi G, Neri M, Zhang JX, et al. Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls[J]. Crit Care, 2018, 22(1):262.
|
| [16] |
Wang HJ, Wang P, Li N, et al. Effects of continuous renal replacement therapy on serum cytokines, neutrophil gelatinase-associated lipocalin, and prognosis in patients with severe acute kidney injury after cardiac surgery[J]. Oncotarget, 2017, 8(6):10628-10636.
|
| [17] |
Kramer P, Wigger W, Rieger J, et al. Arteriovenous haemofiltration: a new and simple method for treatment of over-hydrated patients resistant to diuretics[J]. Klin Wochenschr, 1977, 55(22):1121-1122.
|
| [18] |
Blinzler L, Hausser J, Bödeker H, et al. Conservative treatment of severe necrotizing pancreatitis using early continuous venovenous hemofiltration[J]. Contrib Nephrol, 1991(93):234-236.
|
| [19] |
Gebhardt C, Bödeker H, Blinzler L, et al. Changes in therapy of severe acute pancreatitis[J]. Chirurg, 1994, 65(1):33-40.
|
| [20] |
毛恩强, 汤耀卿, 韩天权, 等. 短时血滤用于重症急性胰腺炎治疗及其机制探讨[J]. 外科理论与实践, 1998(4):231-235.
|
| [21] |
Betteridge DJ, Bakowski M, Taylor KG, et al. Treatment of severe diabetic hypertriglyceridaemia by plasma exchange[J]. Lancet, 1978, 311(8078):1368.
|
| [22] |
Zheng CB, Zheng ZH, Zheng YP. Therapeutic plasma exchange for hyperlipidemic pancreatitis: current evidence and unmet needs[J]. World J Clin Cases, 2021, 9(21):5794-5803.
|
| [23] |
Keskin EB, Koçhan K, Köker IH, et al. The role of plasma exchange in hypertriglyceridemia-induced acute pancreatitis[J]. Eur J Gastroenterol Hepatol, 2019, 31(6):674-677.
|
| [24] |
Yu SS, Yao DQ, Liang XQ, et al. Effects of different triglyceride-lowering therapies in patients with hypertriglyceridemia-induced acute pancreatitis[J]. Exp Ther Med, 2020, 19(4):2427-2432.
|
| [25] |
Lu ZH, Chen YL, Wu YS, et al. The role of double filtration plasmapheresis in hypertriglyceridemic pancreatitis: a propensity score matching analysis[J]. J Clin Apher, 2020, 35(5):388-397.
|
| [26] |
Joury A, Alshehri M, Mahendra A, et al. Therapeutic approaches in hypertriglyceridemia-induced acute pancreatitis: a literature review of available therapies and case series[J]. J Clin Apher, 2020, 35(2): 131-137.
|
| [27] |
Mao EQ. Intensive management of severe acute pancreatitis[J]. Ann Transl Med, 2019, 7(22):687.
|
| [28] |
Hirano R, Namazuda K, Hirata N. Double filtration plasmapheresis: review of current clinical applications[J]. Ther Apher Dial, 2021, 25(2):145-151.
|
| [29] |
Zhang XM, Gu YH, Deng H, et al. Plasma purification treatment relieves the damage of hyperlipidemia to PBMCs[J]. Front Cardiovasc Med, 2021(8):691336.
|
| [30] |
苏琴, 李娟, 徐昆花. 血浆置换联合血液滤过对高脂血症性重症急性胰腺炎的治疗价值评估分析[J]. 中外医疗, 2022, 41(1):76-79.
|
| [31] |
Xu JM, Yang HD, Tian XP. Effects of early hemofiltration on organ function and intra-abdominal pressure in severe acute pancreatitis patients with abdominal compartment syndrome[J]. Clin Nephrol, 2019, 92(5):243-249.
|
| [32] |
冯晓东, 张世杨, 向容,等. 血液灌流联合血液透析滤过治疗高脂血症性急性胰腺炎临床观察[J]. 四川医学, 2017, 38(3):316-319.
|
| [33] |
Tang Y, Zhang L, Fu P, et al. Hemoperfusion plus continuous veno-venous hemofiltration in a pregnant woman with severe acute pancreatitis: a case report[J]. Int Urol Nephrol, 2012, 44(3):987-990.
|
| [34] |
Sun SR, He LJ, Bai M, et al. High-volume hemofiltration plus hemoperfusion for hyperlipidemic severe acute pancreatitis: a controlled pilot study[J]. Ann Saudi Med, 2015, 35(5):352-358.
|
| [35] |
Wang HL, Yu KJ. Sequential blood purification therapy for critical patients with hyperlipidemic severe acute pancreatitis[J]. World J Gastroenterol, 2015, 21(20):6304-6309.
|
| [36] |
Mao EQ, Tang YQ, Zhang SD. Effects of time interval for hemofiltration on the prognosis of severe acute pancreatitis[J]. World J Gastroenterol, 2003, 9(2):373-376.
|
| [37] |
Liu CB, Li M, Cao SX, et al. Effects of HV-CRRT on PCT, TNF-α, IL-4, IL-6, IL-8 and IL-10 in patients with pancreatitis complicated by acute renal failure[J]. Exp Ther Med, 2017, 14(4): 3093-3097.
|
| [38] |
Garg R, Rustagi T. Management of hypertriglyceridemia induced acute pancreatitis[J]. Biomed Res Int, 2018:4721357.
|
| [39] |
Li MX, Liu JF, Lu JD, et al. Plasmadiafiltration ameliorating gut mucosal barrier dysfunction and improving survival in porcine sepsis models[J]. Intensive Care Med Exp, 2016, 4(1):31.
|
| [40] |
Kielstein JT, Kretschmer U, Ernst T, et al. Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study[J]. Am J Kidney Dis, 2004, 43(2):342-349.
|
| [41] |
Lv RG, Yu XX, Zeng WX, et al. Treatment of hypertriglyceridemia-induced acute pancreatitis with plasma diafiltration: a pilot study[J]. Pancreas, 2020, 49(10):e103-105.
|
| [42] |
Ronco C. Sorbents: from bench to bedside. can we combine membrane separation processes and adsorbent based solute removal?[J]. Int J Artif Organs, 2006, 29(9):819-822.
|
| [43] |
Bonavia A, Groff A, Karamchandani K, et al. Clinical utility of extracorporeal cytokine hemoadsorption therapy: a literature review[J]. Blood Purif, 2018, 46(4):337-349.
|
| [44] |
Schädler D, Pausch C, Heise D, et al. The effect of a novel extracorporeal cytokine hemoadsorption device on IL-6 elimination in septic patients: a randomized controlled trial[J]. PLoS One, 2017, 12(10):e0187015.
|
| [45] |
Hassan J, Cader RA, Kong NC, et al. Coupled plasma filtration adsorption (CPFA) plus continuous veno-venous haemofiltration (CVVH) versus CVVH alone as an adjunctive therapy in the treatment of sepsis[J]. EXCLI J, 2013(12):681-692.
|
| [46] |
Yadav D, Pitchumoni CS. Issues in hyperlipidemic pancreatitis[J].J Clin Gastroenterol, 2003, 36(1):54-62.
|
| [47] |
Zhu Y, Pan XL, Zeng H, et al. A study on the etiology, severity, and mortality of 3260 patients with acute pancreatitis according to the revised Atlanta classification in Jiangxi, China over an 8-year period[J]. Pancreas, 2017, 46(4):504-509.
|
| [48] |
Zhang RW, Deng LH, Jin T, et al. Hypertriglyceridaemia-associated acute pancreatitis: diagnosis and impact on severity[J]. HPB, 2019, 21(9):1240-1249.
|
| [49] |
Gubensek J, Buturovic-ponikvar J, Romozi K, et al. Factors affecting outcome in acute hypertriglyceridemic pancreatitis treated with plasma exchange: an observational cohort study[J]. PLoS One, 2014, 9(7):e102748.
|
| [50] |
Laufs U, Parhofer KG, Ginsberg HN, et al. Clinical review on triglycerides[J]. Eur Heart J, 2020, 41(1):99-109c.
|
| [51] |
Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus[J]. Gut, 2013, 62(1):102-111.
|
| [52] |
李非, 曹锋. 中国急性胰腺炎诊治指南(2021)[J]. 中国实用外科杂志, 2021, 41(7):739-746.
|
| [53] |
Singh VK, Wu BU, Bollen TL, et al. Early systemic inflammatory response syndrome is associated with severe acute pancreatitis[J]. Clin Gastroenterol Hepatol, 2009, 7(11):1247-1251.
|
| [54] |
Ostanin AA, Leplina OY, Shevela CY, et al. Inflammatory syndromes (SIRS, MARS, CARS) in patients with surgical infection[J]. Russ J Immunol, 2000, 5(3):289-300.
|